Table of Contents
What is oncotype for prostate cancer?
Oncotype DX GPS test is a genomic test, meaning that it measures the expression of certain genes in prostate cancer cells. The results are reported as a Genomic Prostate Score (GPS) result, which can help you and your doctor make decisions about a management plan that’s best for you.
How is the Oncotype DX test performed?
How is the Oncotype DX Test Performed? A small sample of the tumor tissue is removed during your surgical procedure (biopsy, lumpectomy or mastectomy) and sent to a laboratory for examination. A group of 21 genes in this tissue are analyzed and measured to see if they act in a way that makes your tumor more aggressive.
What is the Oncotype DX test used for?
The Oncotype DX is a test that may predict how likely it is that your breast cancer will return. It also predicts whether you will benefit from having chemotherapy in addition to hormone therapy. The test results can help you and your doctors make a treatment plan that’s right for you.
When is Oncotype DX used for prostate cancer?
The Oncotype DX prostate cancer test gives you and your doctor more information for treatment conversations and decisions. It is intended to be used for men recently diagnosed with early-stage prostate cancer.
How long does an Oncotype DX test take?
How long will it take to get the test results of the Oncotype DX test? Most test results are available within 7 to 10 days from the date your tumor sample is received by the Genomic Health laboratory.
Where is Oncotype DX test done?
You don’t need to do anything specific to prepare for an Oncotype DX test. It’s performed in a laboratory using the cancer cells from a biopsy or surgery.
Who is eligible for Oncotype DX testing?
If you have been diagnosed with DCIS (non-invasive) breast cancer (Stage 0) or early-stage invasive breast cancer (Stage I-IIIa), you may be eligible for the Oncotype DX test, a unique genomic breast cancer test that looks at the activity of certain genes in your tumor to provide personalized information not available …
What is the Oncotype DX genomic prostate Score GPS test?
The Oncotype DX Genomic Prostate Score (GPS) assay is a genomic assay designed for men with low-, intermediate-, and high-risk localized prostate cancer to help guide treatment decisions at the time of diagnosis.
What is a genomic prostate score?
Purpose: The OncotypeDx® GPS (Genomic Prostate Score®) is a 17-gene RNA expression assay intended to help guide treatment decisions in men diagnosed with prostate cancer.
How much does an Oncotype DX test cost?
Various forms of financial assistance and payment plans are available for people facing financial hardships or those who are uninsured or underinsured. The Oncotype DX test costs about $4,000.